Clinical studies must now include 25 percent of patients with darker skin tones
Denosumab Increases Cardiovascular Risk in Dialysis-Dependent Patients
Denosumab has greater preventive effect on fractures, but increased risk for MACE compared with oral bisphosphonates
HDL Cholesterol May Protect Against Brain Atrophy
Association seen between HDL cholesterol and greater grey matter volume in midlife independent of traditional risk factors